Active Member
|
[China]
Address: beijing st 209
Contact name:
rechem-china.co.ltd |
|
|
ZM 306416 an inhibitor of tyrosine kinase RTK signaling pathway involved in anti-cancer agents. Anti-tumor, anti-metastatic agent.
here are our new list:
| ABT-888 | cas:912444-00-9 |
| GSK2126458 | cas:1086062-66-9 |
| BMS777607 | cas:1196681-44-3 |
| BMS5121458 | cas:461432-26-8 |
| VX950 | cas:402957-28-2 |
| Telatinib (BAY 57-9352) | cas:332012-40-5 |
| gsk1904529A | cas:1089283-49-7 |
| LY2157299 | cas:700874-72-2 |
| DMXAA(AS1404,ASA404) | cas:117570-53-3 |
| Brivanib(bms-540215) | cas:649735-46-6 |
| Brivanib alaninate(BMS-582664) | cas:649735-63-7 |
| vx-702 | cas:479543-46-9 |
| abt-869 | cas:796967-16-3 |
| NPS-2143 | cas:284035-33-2 |
| AG014699 | cas:459868-92-9 |
| AZD6244 | cas:606143-52-6 |
| GSK1070916 | cas:942918-07-2 |
| GSK1120212 | cas:871700-17-3 |
| A-674563 | cas:552325-73-2(HCL) |
| MLN8237 | cas:1028486-01-2 |
| AS605240 | cas:648450-29-7 |
| YO01027 | cas:209984-56-5 |
| PKI587 | cas:1197160-78-3 |
| LY2886721 | cas:1262036-50-9, 1262036-49-6 (HCl) |
| GSK690693 | cas:937174-76-0 |
| PF-04691502 | cas:1013101-36-4 |
| SRT1720 | cas:1001645-58-4 |
| PP242 | cas:1092351-67-1 |
| KW-2478 | cas:819812-04-9 |
| YM201636 | cas:371942-69-7 |
| ms-275 | cas:209783-80-2 |
| PI-103 | cas:371935-74-9 |
| PKI-402 | cas:1173204-81-3 |
| GDC0980 | cas:1032754-93-0 |
| GSK1292263 | cas:1032823-75-8, 1032824-54-6 (HCl) |
| PHA665752 | cas:477575-56-7 |
| LY573636 | cas:519055-63-1 |
| KU0063794 | cas:938440-64-3 |
| MDV3100 | cas:915087-33-1 |
| AST-1306 | cas:897383-62-9 |
| Apixaban | cas:503612-47-3 |
| MGCD0103 | cas:726169-73-9+E246 |
| XL880 | cas:849217-64-7 |
| MGCD265 | cas:875337-44-3 |
| R-roscovitine | cas:186692-46-6 |
| sns032 | cas:345627-80-7 |
| ABT-263 | cas:923564-51-6 |
| ABT-737 | cas:852808-04-9 |
| NVP-BGJ398 | cas:872511-34-7 |
| BAY73-4506 | cas:755037-03-7 |
| Roflumilast,Daxas | cas:162401-32-3 |
| Fasudil hydrochloride | cas:105628-07-7 |
| Pelitinib(EKB-569) | cas:257933-82-7 |
| Neratinib(HKI-272) | cas:698387-09-6 |
| Imatinib | cas:152459-95-5 |
| Erlotinib HCL | cas:183319-69-9 |
| Afatinib(BIBW2992) | cas:439081-18-2 |
| PCI-32765 | cas:936563-96-1 |
| AP24534(Ponatinib) | cas:943319-70-8 |
| AT101 | cas:90141-22-3 |
